½ÃÀ庸°í¼­
»óǰÄÚµå
1733308

¼¼°èÀÇ ¼Ò»ý ±â±â ½ÃÀå ±Ô¸ð : Á¦Ç° À¯Çüº°, ȯÀÚ À¯Çüº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° ¹üÀ§ ¹× ¿¹Ãø

Global Resuscitation Devices Market Size By Product, By Patient Type, By End-User, By Geographic Scope And Forecast

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Verified Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 202 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼Ò»ý ±â±â ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø

¼Ò»ý ±â±â ½ÃÀå ±Ô¸ð´Â 2024³â 74¾ï 3,000¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç, 2026-2032³â ¿¬Æò±Õ 4.60%·Î ¼ºÀåÇÏ¿© 2032³â¿¡´Â 106¾ï 5,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼Ò»ý ±â±â ¼¼°è ½ÃÀå ÃËÁø¿äÀÎ

¼Ò»ý ±â±â ½ÃÀåÀÇ ½ÃÀå ÃËÁø¿äÀÎÀº ´Ù¾çÇÑ ¿äÀÎÀÇ ¿µÇâÀ» ¹ÞÀ» ¼ö ÀÖ½À´Ï´Ù. ¿©±â¿¡´Â ´ÙÀ½°ú °°Àº °ÍµéÀÌ Æ÷ÇԵ˴ϴÙ.

¿Ü»ó ¹× ½ÉÁ¤Áö ºñÀ² Áõ°¡ ½ÉÁ¤Áö, Áß»ó ¹× ±âŸ ÀÇ·á À§±âÀÇ ¹ß»ý ºóµµ°¡ Áõ°¡ÇÔ¿¡ µû¶ó ¼Ò»ý ±â±âÀÇ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. °í·ÉÈ­, ¶óÀÌÇÁ½ºÅ¸ÀÏ º¯È­, µµ½ÃÈ­ µî ¿Ü»ó ¹× °©ÀÛ½º·± ½ÉÀ帶ºñÀÇ À§ÇèÀ» Áõ°¡½ÃŰ´Â ¿äÀÎÀÌ Àֱ⠶§¹®¿¡ ½ÃÀåÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù.

±â¼ú °³¹ß : ±â°è½Ä ½ÉÆó¼Ò»ý¼ú ÈÞ´ë¿ë ±â±â, ½Ç½Ã°£ Çǵå¹éÀÌ °¡´ÉÇÑ ÀÚµ¿ ü¿ÜÇü Á¦¼¼µ¿±â(AED), ÷´Ü ±âµµ °ü¸® µµ±¸ °³¹ß µî ¼Ò»ý ±â±â ±â¼úÀÇ Áö¼ÓÀûÀÎ °³¼±À¸·Î ±â±âÀÇ È¿°ú, »ç¿ë ÆíÀǼº, ȯÀÚ Ä¡·á °á°ú°¡ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. ±â¼úÀÇ ¹ßÀüÀº ±â±âÀÇ ¼º´É, ½Å·Ú¼º, »ç¿ëÀÚ ÆíÀǼºÀ» Çâ»ó½ÃÄÑ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÕ´Ï´Ù. ½ÉÁ¤Áö ¹× ±âŸ ÀÀ±Þ»óȲ¿¡¼­ »ýÁ¸À²À» ³ôÀ̱â À§ÇÑ Á¶±â °³ÀÔ°ú ¸ñ°ÝÀÚ ½ÉÆó¼Ò»ý¼ú(CPR)ÀÇ Á߿伺Àº °øÁߺ¸°Ç ³ë·Â°ú ÀÎ½Ä Á¦°í Ä·ÆäÀÎÀ» ÅëÇØ °­Á¶µÇ°í ÀÖ½À´Ï´Ù. ÀϹÝÀÎ ½ÉÆó¼Ò»ý¼ú¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁü¿¡ µû¶ó ÀϹÝÀοë AED¿Í ±³À° ÇÁ·Î±×·¥ µî ½±°Ô ±¸ÇÒ ¼ö ÀÖ°í »ç¿ëÇϱ⠽¬¿î ¼Ò»ý ±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

AEDÀÇ ´ëÁßÀû »ç¿ëÀ» Àǹ«È­ÇÏ´Â ¹ý·ü : °ø°øÀå¼Ò, Á÷Àå, Çб³, ±³Åë ¿äÃæÁö¿¡ AED ¼³Ä¡¸¦ Àǹ«È­ÇÏ´Â ¹ý·ü ¹× ±ÔÁ¤Àº ¼Ò»ý ±â±âÀÇ ¹èÄ¡ ¼ö¸¦ Áõ°¡½ÃÅ´À¸·Î½á ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀÔ´Ï´Ù. °ø°ø Á¢±Ù¼º AED ÇÁ·Î±×·¥Àº Áö¿ª»çȸ¿¡¼­ »ý¸í À¯Áö Ä¡·á¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» °³¼±ÇÏ°í ½ÉÁ¤Áö ȯÀÚ°¡ ½Å¼ÓÇÑ Á¦¼¼µ¿À» ¹ÞÀ» ¼ö ÀÖ´Â °¡´É¼ºÀ» ³ôÀÔ´Ï´Ù.

ÀÇ·áºñ ÁöÃâ È®´ë : Àα¸ Áõ°¡, °í·ÉÈ­, ÀÇ·á ÀÎÇÁ¶ó °³¼± µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ Àü ¼¼°èÀûÀ¸·Î ÀÇ·áºñ ÁöÃâÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¼Ò»ý ±â±â ¹× °ü·Ã ÀÇ·á ±â¼ú¿¡ ´ëÇÑ ÅõÀÚ°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¼Ò»ý ±â±âÀÇ ±¸¸Å´Â ȯÀÚ Ä¡·á °á°ú¿Í ÀÀ±Þ ´ëÀÀ ´É·ÂÀ» Çâ»ó½Ã۱â À§ÇØ ÀÇ·áÁø¿¡°Ô ÃÖ¿ì¼± ¼øÀ§·Î ²ÅÈ÷°í ÀÖ½À´Ï´Ù.

ȯÀÚ ¾ÈÀü°ú Ä¡·áÀÇ Áú¿¡ ´ëÇÑ Á߿伺 : Áõ°Å¿¡ ±â¹ÝÇÑ ¼Ò»ý¼ú ÀýÂ÷ ¹× °¡À̵å¶óÀÎÀÇ µµÀÔÀº ÀÇ·á ±â°ü°ú ±ÔÁ¦ ±â°üÀÌ È¯ÀÚ ¾ÈÀü°ú Ä¡·áÀÇ ÁúÀ» ¿ì¼±½ÃÇÏ´Â ¹è°æ¿¡ ÀÖ½À´Ï´Ù. ÀÇ·á Àü¹®°¡¿Í ±¸¸ÅÀÚ´Â ¹Ì±¹½ÉÀåÇùȸ(AHA)ÀÇ ½ÉÆó¼Ò»ý¼ú ¹× ÀÀ±Þ ½ÉÇ÷°ü Ä¡·á °¡À̵å¶óÀΰú °°Àº °øÀÎµÈ ±Ô¹ü°ú ÀýÂ÷¸¦ µû¸£´Â ¼Ò»ý¼úÀ» ¼±È£Çϰí ÀÖ½À´Ï´Ù.

±³À° ¹× ÈÆ·Ã ÇÁ·Î±×·¥ ÀÇ·áÁø, ±¸±Þ´ë¿ø, ÀϹÝÀÎÀ» ´ë»óÀ¸·Î ÇÑ ±³À° ¹× ÈÆ·Ã ÇÁ·Î±×·¥Àº ¼Ò»ý¼ú°ú ¼Ò»ý ±â±â »ç¿ë¿¡ ´ëÇÑ ÀνÄ, Àڽۨ, ¼÷·Ãµµ¸¦ ³ôÀÌ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù. ¼Ò»ý ±â±â¸¦ »ç¿ëÇÏ´Â »ç¶÷ÀÇ ¼ö¸¦ ´Ã¸®°í ÀÀ±Þ»óȲ¿¡¼­ È¿À²ÀûÀ¸·Î »ç¿ëÇϵµ·Ï Àå·ÁÇÔÀ¸·Î½á ±³À° Ȱµ¿Àº ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù.

ºñ»ó»çÅ ´ëºñ ¹× Àç³­ ´ëÀÀ : ºñ»ó»çÅ ´ëºñ ¹× Àç³­ ´ëÀÀ ´É·ÂÀÇ Á߿伺Àº ÀÚ¿¬ÀçÇØ, ´ë·® ÀθíÇÇÇØ, °øÁߺ¸°Ç ¹®Á¦¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ´õ¿í ºÎ°¢µÇ°í ÀÖ½À´Ï´Ù. Àç³­¿¡ ´ëÇÑ ´ëºñ¸¦ °­È­ÇÏ°í ¿Ü»ó ¹× °©ÀÛ½º·± ½ÉÀ帶ºñÀÇ ¿µÇâÀ» ÁÙÀ̱â À§ÇØ Á¤ºÎ, ÀÇ·á ±â°ü ¹× Àç³­ ´ëÀÀ ±â°üÀº ¼Ò»ý ±â±â¿Í ÈÆ·Ã¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù.

¼Ò»ý ±â±â ¼¼°è ½ÃÀå ¾ïÁ¦¿äÀÎ

¼Ò»ý ±â±â ½ÃÀå¿¡´Â ¸î °¡Áö ¿äÀÎÀÌ ¾ïÁ¦¿äÀÎÀ¸·Î ÀÛ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿©±â¿¡´Â ´ÙÀ½°ú °°Àº °ÍµéÀÌ ÀÖ½À´Ï´Ù.

³ôÀº ±â±â ºñ¿ë : ÀÚµ¿½ÉÀåÃæ°Ý±â(AED), ±â°è½Ä ½ÉÆó¼Ò»ý¼ú(CPR) ±â±â, ±âµµ °ü¸® ½Ã½ºÅÛ µî ¼Ò»ý ±â±âÀÇ Á¦Á¶ ¹× ±¸ÀÔ¿¡ ¸¹Àº ºñ¿ëÀÌ ¼Ò¿äµË´Ï´Ù. ƯÈ÷ ¿¹»êÀÌ ÇÑÁ¤µÈ ÀÇ·á ±â°ü¿¡¼­ ÀÌ·¯ÇÑ ±â¼úÀÇ »ç¿ëÀº ³ôÀº ºñ¿ëÀ¸·Î ÀÎÇØ Á¦ÇÑµÉ ¼ö ÀÖ½À´Ï´Ù.

±³À° ¹× ÈÆ·Ã¿¡ ´ëÇÑ Á¢±Ù¼º Á¦ÇÑ : ÀϹÝÀÎÀ̳ª ÀÇ·á Àü¹®°¡ ¸ðµÎ ¼Ò»ý ±â±â¸¦ È¿°úÀûÀ¸·Î »ç¿ëÇϱâ À§Çؼ­´Â ±³À° ¹× ÈÆ·ÃÀÌ ÇÊ¿äÇÕ´Ï´Ù. ±³À° ÇÁ·Î±×·¥¿¡ ´ëÇÑ Á¢±Ù¼º Á¦ÇÑ, ºÒÃæºÐÇÑ ±³À° ÀÚ·á, ¼Ò»ý¼ú ±³À°ÀÇ Á߿伺¿¡ ´ëÇÑ Áö½Ä ºÎÁ·Àº ±â±âÀÇ È¿°ú¿Í Ȱ¿ëÀ» ÀúÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

±ÔÁ¦ Áؼö : ǰÁú, ¾ÈÀü¼º, À¯È¿¼ºÀ» º¸ÀåÇϱâ À§ÇØ ¼Ò»ý ±â±â´Â ¾ö°ÝÇÑ ±ÔÁ¦¸¦ ÁؼöÇØ¾ß ÇÕ´Ï´Ù. À¯·´ÀÇ À¯·´ÀǾàǰû(EMA), ¹Ì±¹ ½ÄǰÀǾ౹(FDA) µîÀÇ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©¸¦ ÁؼöÇϱâ À§Çؼ­´Â ¸¹Àº ½Ã°£°ú ºñ¿ëÀÌ ¼Ò¿äµÇ¾î ½ÃÀå ÁøÀÔ°ú Á¦Ç°È­°¡ Áö¿¬µÉ ¼ö ÀÖ½À´Ï´Ù. ÀÇ·á ÀÎÇÁ¶ó´Â Áö¿ª°ú ȯ°æ¿¡ µû¶ó Å©°Ô ´Ù¸¨´Ï´Ù. ½Ã¼³ÀÌ Àß °®ÃçÁø µµ½ÉÀÇ º´¿øºÎÅÍ ÀÇ·á ½Ã¼³¿¡ ´ëÇÑ Á¢±Ù¼ºÀÌ Á¦Çѵǰųª ÀÚ¿øÀÌ ºÎÁ·ÇÑ °í¸³µÈ Áö¿ª±îÁö ±× ¹üÀ§´Â ¸Å¿ì ´Ù¾çÇÕ´Ï´Ù. ÀÎÇÁ¶ó°¡ ºÎÁ·ÇÏ¸é Æ¯È÷ ÀÀ±Þ »óȲ¿¡¼­ ¼Ò»ý ±â±âÀÇ ¹èÄ¡¿Í »ç¿ëÀÌ ¾î·Á¿öÁý´Ï´Ù. ¿©±â¿¡´Â Àü·Â, ±³Åë¼ö´Ü, ¼÷·ÃµÈ Àη ºÎÁ· µîÀÌ Æ÷ÇԵ˴ϴÙ.

°æÀï »óȲ : °æÀïÀÌ Ä¡¿­ÇÑ ¼Ò»ý ±â±â »ê¾÷¿¡´Â ´Ù¾çÇÑ Á¦Ç°°ú ¼Ö·ç¼ÇÀ» Á¦°øÇÏ´Â ¸¹Àº Á¦Á¶¾÷ü°¡ Á¸ÀçÇÕ´Ï´Ù. ƯÈ÷ ±âº» AED³ª ¼öµ¿½Ä ÀΰøÈ£Èí±â¿Í °°Àº »óǰȭµÈ Á¦Ç°¿¡¼­´Â °­·ÂÇÑ °æÀïÀ¸·Î ÀÎÇØ ¼öÀÍ·ü Ç϶ô, °¡°Ý ¾Ð¹Ú, ½ÃÀå Æ÷È­ Çö»óÀÌ ¹ß»ýÇÒ ¼ö ÀÖ½À´Ï´Ù.

ȯÀÚ ¼öÀÇ ¿ªÇÐ : »ýȰ½À°üÀÇ º¯È­, ÀÇ·á ¹ßÀü, Àα¸Åë°è µî ¸¹Àº º¯¼ö°¡ ½ÉÁ¤Áö ¹× ¼Ò»ý¼úÀÌ ÇÊ¿äÇÑ ±âŸ Áõ»óÀÇ ¹ß»ý ºóµµ¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù. ȯÀÚ Áý´ÜÀÇ º¯µ¿Àº ¼Ò»ý ±â±â ¹× °ü·Ã ¼­ºñ½ºÀÇ Çʿ伺¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù.

´ëÁßÀÇ Àνİú ³«ÀÎ : ¼Ò»ý¼ú¿¡ ´ëÇÑ ´ëÁßÀÇ ÀνÄÀ» ³ôÀÌ°í ±³À°ÇÏ·Á´Â ³ë·Â¿¡µµ ºÒ±¸ÇÏ°í ¼Ò»ý¼úÀº ¿©ÀüÈ÷ ³«ÀÎÂïÈ÷°Å³ª µÎ·Á¿òÀÇ ´ë»óÀÌ µÉ ¼ö ÀÖÀ¸¸ç, ƯÈ÷ ÀÏ¹Ý ´ëÁßµé »çÀÌ¿¡¼­´Â ´õ¿í ±×·¯ÇÕ´Ï´Ù. ½ÉÁ¤Áö ¹× ±âŸ ÀÇ·á ÀÀ±Þ »óȲÀÇ »ýÁ¸À²À» ³ôÀ̱â À§Çؼ­´Â ÀÏ¹Ý ´ëÁßÀÇ ÀúÇ×À» ±Øº¹Çϰí, ¸ñ°ÝÀÚÀÇ °³ÀÔÀ» À¯µµÇØ¾ß ÇÕ´Ï´Ù.

º¸Çè Àû¿ë ¹× »óȯ : ¼Ò»ý ±â±â ¹× °ü·Ã ¼­ºñ½º¿¡ ´ëÇÑ »óȯ ±ÔÁ¤ ¹× Àû¿ë ¼öÁØÀº ÀÇ·á Á¦µµ ¹× ÁöºÒÀÚ¿¡ µû¶ó ´Ù¸¨´Ï´Ù. ÀÇ·á ¼­ºñ½º Á¦°øÀÚ´Â ºÒÃæºÐÇÑ »óȯÀ²°ú °áÁ¦ Á¦ÇÑÀ¸·Î ÀÎÇØ ¼Ò»ý ±â±â¿Í ±³À° ÇÁ·Î±×·¥¿¡ ÅõÀÚÇÒ ¿©·ÂÀÌ ¾øÀ» ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼Ò»ý ±â±â ¼¼°è ½ÃÀå ¼Ò°³

  • ½ÃÀå °³¿ä
  • Á¶»ç ¹üÀ§
  • °¡Á¤

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå VERIFIED MARKET RESEARCH Á¶»ç ¹æ¹ý

  • µ¥ÀÌÅÍ ¸¶ÀÌ´×
  • °ËÁõ
  • 1Â÷ ÀÚ·á
  • µ¥ÀÌÅÍ ¼Ò½º ¸®½ºÆ®

Á¦4Àå ¼Ò»ý ±â±â ¼¼°è ½ÃÀå Àü¸Á

  • °³¿ä
  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
  • Porter's Five Forces ¸ðµ¨
  • ¹ë·ùüÀÎ ºÐ¼®

Á¦5Àå ¼Ò»ý ±â±â ¼¼°è ½ÃÀå : Á¦Ç°º°

  • °³¿ä
  • ±âµµ °ü¸® ±â±â
  • ü¿Ü½Ä Á¦¼¼µ¿±â
  • ´ë·ù½Ä ¿Â¿­ ´ã¿ä
  • ±âŸ ¼Ò»ý ±â±â

Á¦6Àå ¼Ò»ý ±â±â ¼¼°è ½ÃÀå : ȯÀÚ À¯Çüº°

  • °³¿ä
  • ¼ºÀΠȯÀÚ
  • ¼Ò¾Æ ȯÀÚ

Á¦7Àå ¼Ò»ý ±â±â ¼¼°è ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ¿Í ½ÉÀå ¼¾ÅÍ
  • º´¿øÀü ÀÀ±Þóġ
  • ±âŸ

Á¦8Àå ¼Ò»ý ±â±â ¼¼°è ½ÃÀå : Áö¿ªº°

  • °³¿ä
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ±âŸ
    • ¶óƾ¾Æ¸Þ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦9Àå ¼Ò»ý ±â±â ¼¼°è ½ÃÀå °æÀï ±¸µµ

  • °³¿ä
  • °¢»çÀÇ ½ÃÀå ¼øÀ§
  • ÁÖ¿ä °³¹ß Àü·«

Á¦10Àå ±â¾÷ °³¿ä

  • Dragerwerk AG & Co. KGaA
  • Koninklijke Philips N.V
  • Zoll Medical Corporation
  • Mindray
  • Medtronic
  • Cardinal Health
  • Nihon Kohden Corporation
  • Smiths Medical
  • Physio-Control Corporation
  • GE Healthcare

Á¦11Àå ºÎ·Ï

  • °ü·Ã Á¶»ç
ksm 25.06.10

Resuscitation Devices Market Size And Forecast

Resuscitation Devices Market size was valued at USD 7.43 Billion in 2024 and is projected to reach USD 10.65 Billion by 2032, growing at a CAGR of 4.60% during the forecast period 2026-2032.

Global Resuscitation Devices Market Drivers

The market drivers for the Resuscitation Devices Market can be influenced by various factors. These may include:

Growing Rate of Traumatic Injury and Cardiac Arrest: The need for resuscitation equipment is increasing due to the increased frequency of cardiac arrest, severe injuries, and other medical crises. The market is growing because of factors like ageing populations, changing lifestyles, and urbanisation that raise the risk of traumatic injuries and sudden cardiac arrest.

Technological Developments: Continuous improvements in resuscitation device technology, such as the creation of mechanical CPR portables, automated external defibrillators (AEDs) with real-time feedback, and sophisticated airway management tools, enhance the efficacy, user-friendliness, and patient outcomes of the devices. Technological advancements increase device performance, dependability, and user happiness, which propels market growth. The importance of early intervention and bystander cardiopulmonary resuscitation (CPR) in boosting survival rates for cardiac arrest and other medical emergencies is emphasised by public health efforts and awareness campaigns. Demand for easily available and user-friendly resuscitation equipment, such as public AEDs and training programmes, is driven by the growing emphasis on bystander CPR.

Laws Requiring Public Access to AEDs: By increasing the number of resuscitation devices deployed, laws and regulations mandating the installation of AEDs in public areas, workplaces, schools, and transportation hubs stimulate market growth. Public access AED programmes improve community access to life-saving therapies and raise the possibility that cardiac arrest victims may receive rapid defibrillation.

Growing Healthcare Expenditure: Investment in resuscitation equipment and related medical technology is supported by rising global healthcare expenditures, which are fueled by factors like population growth, ageing demographics, and the development of healthcare infrastructure. Purchasing resuscitation equipment is a top priority for healthcare practitioners in order to enhance patient outcomes and emergency response capabilities.

Emphasis on Patient Safety and Quality of treatment: The implementation of evidence-based resuscitation procedures and guidelines is fueled by the priority placed on patient safety and quality of treatment by healthcare organisations and regulatory bodies. Healthcare professionals and buyers favour resuscitation devices that follow accepted norms and procedures, such as the American Heart Association's (AHA) guidelines for CPR and emergency cardiovascular care.

Initiatives for Training and Education: Programmes for educating and training medical personnel, first responders, and laypeople are essential for raising awareness, self-assurance, and proficiency in resuscitation procedures and device use. By increasing the number of people using resuscitation equipment and encouraging their efficient usage in emergency situations, training activities fuel market growth.

Emergency Preparedness and Disaster Response: The significance of emergency preparedness and disaster response capabilities is highlighted by the increased awareness of natural disasters, mass casualty situations, and public health issues. In order to improve preparedness for catastrophes and lessen the effects of trauma and sudden cardiac arrest, governments, healthcare institutions, and disaster response organisations invest in resuscitation equipment and training.

Global Resuscitation Devices Market Restraints

Several factors can act as restraints or challenges for the Resuscitation Devices Market. These may include:

High Device Cost: The production and acquisition of resuscitation equipment, such as automated external defibrillators (AEDs), mechanical CPR devices, and airway management systems, can be costly. The use of these technologies may be hindered by their high cost, especially in healthcare institutions with tight budgets or resource limitations.

Restricted Access to Education and Training: Both laypeople and healthcare professionals need to get education and training in order to utilise resuscitation equipment effectively. Device efficacy and utilisation might be hampered by restricted access to training programmes, insufficient educational materials, and a lack of knowledge on the significance of resuscitation training.

Regulatory Compliance: To guarantee their quality, safety, and efficacy, resuscitation equipment must adhere to strict regulations. Market entry and product commercialization may be delayed by the time-consuming and expensive process of complying with regulatory frameworks, such as the European Medicines Agency (EMA) in Europe and the Food and Drug Administration (FDA) in the United States. Healthcare infrastructure varies greatly between locations and settings. It can range from well-equipped urban hospitals to isolated or resource-constrained places with restricted access to medical facilities. Inadequate infrastructure can make it difficult to deploy and use resuscitation equipment, especially in an emergency. This includes a lack of power, transportation, and skilled personnel.

Competitive Landscape: There are many manufacturers offering a variety of goods and solutions in the highly competitive resuscitation devices industry. Strong competition can cause margin erosion, pricing pressure, and market saturation, especially for commoditized products like basic AEDs and manual resuscitators.

Patient Population Dynamics: A number of variables, including changes in lifestyle, medical developments, and demographics, might affect the frequency of cardiac arrest and other conditions needing resuscitation. Patient population variability may have an effect on the need for resuscitation equipment and related services.

Public Perception and Stigma: Using resuscitation equipment may still be stigmatised or met with fear, especially among laypeople, despite efforts to raise awareness and educate the public about the procedure. Improving the survival rates of cardiac arrest and other medical emergencies will continue to require overcoming public resistance and encouraging bystander intervention.

Insurance Coverage and Reimbursement: Different healthcare systems and payers have different reimbursement rules and levels of coverage for resuscitation equipment and related services. Healthcare providers may not be able to afford to invest in resuscitation equipment and training programmes due to inadequate reimbursement rates or restrictions on payment.

Global Resuscitation Devices Market Segmentation Analysis

The Global Resuscitation Devices Market is Segmented on the basis of Product, Patient Type, End-User, and Geography.

Resuscitation Devices Market, By Product

  • Airway Management Devices
  • External Defibrillators
  • Convective Warming Blankets
  • Other Resuscitation Devices

Based on Product, the market is bifurcated into Airway Management Devices, External Defibrillators, Convective Warming Blankets, and Other Resuscitation Devices. The airway management devices segment is anticipated to hold the largest market share owing to an increase in the number of patients diagnosed with bronchitis and asthma and the rising prevalence of COPD.

Resuscitation Devices Market, By Patient Type

  • Adult Patients
  • Pediatric Patients
  • Others

Based on Patient Type, the market is bifurcated into Adult Patients and Pediatric Patients. The adult patient segment is expected to lead the market because of the increase in the adult patient population due to chronic and cardiovascular diseases.

Resuscitation Devices Market, By End-User

  • Hospitals
  • Ambulatory Surgical Centers & Cardiac Centers
  • Pre-Hospital Care Settings
  • Other End Users

Based on End-User, the market is bifurcated into Hospitals, Ambulatory Surgical Centers & Cardiac Centers, Pre-Hospital Care Settings, and Other End Users. The hospitals, ambulatory surgical centers, and cardiac centers segment hold the largest share because of the rise in bulk purchasing, a growing number of road accident and trauma cases, and an increase in the number of donations with regard to the purchase of defibrillators.

Resuscitation Devices Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world
  • On the basis of Regional Analysis, the Global Resuscitation Devices Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America is expected to hold the largest market share in the forecast period. The growth can be attributed to the increase in the geriatric population, advancements in the development of resuscitation devices, and a rise in the incidences of cardiac and respiratory diseases in this region.

Key Players

  • The major players in the Resuscitation Devices Market are:
  • Drgerwerk AG & Co. KGaA
  • Koninklijke Philips N.V
  • Zoll Medical Corporation
  • Mindray
  • Medtronic
  • Cardinal Health
  • Nihon Kohden Corporation
  • Smiths Medical
  • Physio-Control Corporation
  • GE Healthcare

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL RESUSCITATION DEVICES MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL RESUSCITATION DEVICES MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL RESUSCITATION DEVICES MARKET, BY PRODUCT

  • 5.1 Overview
  • 5.2 Airway Management Devices
  • 5.3 External Defibrillators
  • 5.4 Convective Warming Blankets
  • 5.5 Other Resuscitation Devices

6 GLOBAL RESUSCITATION DEVICES MARKET, BY PATIENT TYPE

  • 6.1 Overview
  • 6.2 Adult Patients
  • 6.3 Pediatric Patients

7 GLOBAL RESUSCITATION DEVICES MARKET, BY END-USER

  • 7.1 Ambulatory Surgical Centers & Cardiac Centers
  • 7.2 Pre-Hospital Care Settings
  • 7.3 Other End Users

8 GLOBAL RESUSCITATION DEVICES MARKET, BY GEOGRAPHY

  • 8.1 Overview
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 U.K.
    • 8.3.3 France
    • 8.3.4 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Rest of Asia Pacific
  • 8.5 Rest of the World
    • 8.5.1 Latin America
    • 8.5.2 Middle East & Africa

9 GLOBAL RESUSCITATION DEVICES MARKET COMPETITIVE LANDSCAPE

  • 9.1 Overview
  • 9.2 Company Market Ranking
  • 9.3 Key Development Strategies

10 COMPANY PROFILES

  • 10.1 Dragerwerk AG & Co. KGaA
    • 10.1.1 Overview
    • 10.1.2 Financial Performance
    • 10.1.3 Product Outlook
    • 10.1.4 Key Developments
  • 10.2 Koninklijke Philips N.V
    • 10.2.1 Overview
    • 10.2.2 Financial Performance
    • 10.2.3 Product Outlook
    • 10.2.4 Key Developments
  • 10.3 Zoll Medical Corporation
    • 10.3.1 Overview
    • 10.3.2 Financial Performance
    • 10.3.3 Product Outlook
    • 10.3.4 Key Developments
  • 10.4 Mindray
    • 10.4.1 Overview
    • 10.4.2 Financial Performance
    • 10.4.3 Product Outlook
    • 10.4.4 Key Developments
  • 10.5 Medtronic
    • 10.5.1 Overview
    • 10.5.2 Financial Performance
    • 10.5.3 Product Outlook
    • 10.5.4 Key Developments
  • 10.6 Cardinal Health
    • 10.6.1 Overview
    • 10.6.2 Financial Performance
    • 10.6.3 Product Outlook
    • 10.6.4 Key Developments
  • 10.7 Nihon Kohden Corporation
    • 10.7.1 Overview
    • 10.7.2 Financial Performance
    • 10.7.3 Product Outlook
    • 10.7.4 Key Developments
  • 10.8 Smiths Medical
    • 10.8.1 Overview
    • 10.8.2 Financial Performance
    • 10.8.3 Product Outlook
    • 10.8.4 Key Developments
  • 10.9 Physio-Control Corporation
    • 10.9.1 Overview
    • 10.9.2 Financial Performance
    • 10.9.3 Product Outlook
    • 10.9.4 Key Developments
  • 10.10 GE Healthcare
    • 10.10.1 Overview
    • 10.10.2 Financial Performance
    • 10.10.3 Product Outlook
    • 10.10.4 Key Developments

11 Appendix

  • 11.1 Related Research
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦